Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
LIXT
#3812
Lixte Biotechnology Holdings, Inc. Common Stock
2.9
0
-2.68%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
-2.68%
Monatliche Änderung
-15.20%
6 month change
-15.20%
Jahresänderung
+110.14%
Vorheriger Schlusskurs
2.9
8
Open
2.8
9
Bid
Ask
Low
2.8
5
High
2.9
4
Volumen
20
Märkte
Aktien
Gesundheitswesen
LIXT
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
2.25 M
2.68 M
2.68 M
4.56 M
5.7 M
—
Valuation ratios
Enterprise value
6.07 M
8.7 M
5.36 M
3.24 M
28.36 M
45.66 M
Price to earnings ratio
-1.12
-1.28
-0.83
-0.7
-4.26
-7.08
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
-1.16
-1.44
-0.94
-0.82
-6.09
-9.3
Price to book ratio
-1.32
-1.71
-0.33
-0.32
-3.32
-5.68
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.58
-0.54
-0.47
-0.65
-0.36
-2.02
Return on equity %
-0.72
-0.75
-0.61
-1.19
-0.4
-2.95
Return on invested capital %
—
—
—
—
—
—
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
5.13
1.12
4.26
1.84
10.42
17.65
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
0
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.43
-0.27
-0.23
-0.19
-0.24
-0.93
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
0.73
0.11
0.56
0.34
0.76
1.77
Net current asset value per share
0.75
0.16
0.61
0.38
1.43
2.58
Tangible book value per share
-0.95
-1.19
-0.95
0.25
0.62
-1.26
Working capital per share
0.6
0.02
0.47
0.17
1.29
1.95
Book value per share
-0.95
-1.19
-0.95
0.25
0.62
-1.26
Nachrichten
LIXTE Biotechnology appoints Sidney Braun to lead Liora subsidiary
LIXTE erweitert Studie zur Behandlung von Ovarialkarzinom
LIXTE expands clinical trial for ovarian cancer treatment
Lixte Biotechnology-Aktie fällt nach Direktplatzierung über 4,3 Mio. US-Dollar
Spartan Capital begleitet 4,3-Millionen-Dollar-Angebot von Lixte
Lixte Biotechnology stock falls after $4.3 million direct offering
Spartan Capital acts as placement agent in Lixte’s $4.3 million offering
Lixte Biotechnology: Aktie fällt nach Direktplatzierung über 4,3 Mio. $
Lixte Biotechnology stock falls after $4.3 million direct offering
Lixte Biotechnology raises $4.3 million in registered direct offering
Lixte Biotechnology: Aktionäre genehmigen neue Verwaltungsratsmitglieder und erweiterten Aktienplan
Lixte Biotechnology shareholders approve board nominees and stock plan amendment